logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9655869 B1

PDFFull Text
Date of Patent:
May. 23, 2017

Filed:

Oct. 20, 2014

Estrogen antagonists as treatments for sclerosing disorders

Applicant:

University of Pittsburgh—of the Commonwealth System of Higher Education, Pittsburgh, PA (US);

Inventors:

Carol A. Feghali-Bostwick, Pittsburgh, PA (US);

Pamela Anne Hershberger, Coraopolis, PA (US);

Assignee:

UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Pittsburgh, PA (US);

Attorney:

Baker Botts L.L.P.

Primary Examiner:

Dennis Heyer

Int. Cl.
CPC ...
A61K 31/661 (2006.01); A61K 31/566 (2006.01); A61K 31/453 (2006.01); A61K 31/4535 (2006.01); A61K 31/4453 (2006.01); A61K 31/4025 (2006.01); A61K 31/216 (2006.01); A61K 31/138 (2006.01); A61K 31/10 (2006.01); A61K 31/085 (2006.01); A61K 31/57 (2006.01); A61K 31/06 (2006.01); A61K 31/565 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/138 (2013.01); A61K 31/085 (2013.01); A61K 31/10 (2013.01); A61K 31/216 (2013.01); A61K 31/4025 (2013.01); A61K 31/4453 (2013.01); A61K 31/453 (2013.01); A61K 31/4535 (2013.01); A61K 31/565 (2013.01); A61K 31/566 (2013.01); A61K 31/57 (2013.01); A61K 31/661 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention relates to methods and compositions for treating a subject suffering from a sclerosing disorder, comprising administering, to the subject, an effective amount of an estrogen receptor antagonist ('ERANT'), wherein said ERANT has essentially no estrogen receptor agonist activity under physiologic conditions.

Find Patent Forward Citations

Feghali-Bostwick, Carol. (2017). Estrogen antagonists as treatments for sclerosing disorders (U.S. Patent No. 9655869). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9655869

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…